Report Detail

Pharma & Healthcare Global Finasteride Market Professional Survey Report 2018

  • RnM2965547
  • |
  • 18 February, 2019
  • |
  • Global
  • |
  • 114 Pages
  • |
  • XYZResearch
  • |
  • Pharma & Healthcare

Table of Contents

    Global Finasteride Market Professional Survey Report 2017

      1 Report Overview

      • 1.1 Definition and Specification
      • 1.2 Report Overview
        • 1.2.1 Manufacturers Overview
        • 1.2.2 Regions Overview
        • 1.2.3 Type Overview
        • 1.2.4 Application Overview
      • 1.3 Industrial Chain
        • 1.3.1 Finasteride Overall Industrial Chain
        • 1.3.2 Upstream
        • 1.3.3 Downstream
      • 1.4 Industry Situation
        • 1.4.1 Industrial Policy
        • 1.4.2 Product Preference
        • 1.4.3 Economic/Political Environment
      • 1.5 SWOT Analysis

      2 Market Analysis by Types

      • 2.1 Overall Market Performance(Volume)
        • 2.1.1 Type I Market Performance (Volume)
        • 2.1.2 Type II Market Performance (Volume)
      • 2.2 Overall Market Performance(Value)
        • 2.1.1 Type I Market Performance (Value)
        • 2.1.2 Type II Market Performance (Value)

      3 Product Application Market

      • 3.1 Overall Market Performance (Volume)
        • 3.1.1 Benign Prostatic Hyperplasia Market Performance (Volume)
        • 3.1.2 Male Pattern Baldness Market Performance (Volume)
        • 3.1.3 Other Market Performance (Volume)

      4 Manufacturers Profiles/Analysis

      • 4.1 Merck
        • 4.1.1 Merck Profiles
        • 4.1.2 Merck Product Information
        • 4.1.3 Merck Finasteride Business Performance
        • 4.1.4 Merck Finasteride Business Development and Market Status
      • 4.2 Actavis
        • 4.2.1 Actavis Profiles
        • 4.2.2 Actavis Product Information
        • 4.2.3 Actavis Finasteride Business Performance
        • 4.2.4 Actavis Finasteride Business Development and Market Status
      • 4.3 Sandoz
        • 4.3.1 Sandoz Profiles
        • 4.3.2 Sandoz Product Information
        • 4.3.3 Sandoz Finasteride Business Performance
        • 4.3.4 Sandoz Finasteride Business Development and Market Status
      • 4.4 Teva Pharmaceuticals
        • 4.4.1 Teva Pharmaceuticals Profiles
        • 4.4.2 Teva Pharmaceuticals Product Information
        • 4.4.3 Teva Pharmaceuticals Finasteride Business Performance
        • 4.4.4 Teva Pharmaceuticals Finasteride Business Development and Market Status
      • 4.5 Cipla
        • 4.5.1 Cipla Profiles
        • 4.5.2 Cipla Product Information
        • 4.5.3 Cipla Finasteride Business Performance
        • 4.5.4 Cipla Finasteride Business Development and Market Status
      • 4.6 RelonChem
        • 4.6.1 RelonChem Profiles
        • 4.6.2 RelonChem Product Information
        • 4.6.3 RelonChem Finasteride Business Performance
        • 4.6.4 RelonChem Finasteride Business Development and Market Status
      • 4.7 Dr. Reddy
        • 4.7.1 Dr. Reddy Profiles
        • 4.7.2 Dr. Reddy Product Information
        • 4.7.3 Dr. Reddy Finasteride Business Performance
        • 4.7.4 Dr. Reddy Finasteride Business Development and Market Status
      • 4.8 Accord Pharmaceuticals
        • 4.8.1 Accord Pharmaceuticals Profiles
        • 4.8.2 Accord Pharmaceuticals Product Information
        • 4.8.3 Accord Pharmaceuticals Finasteride Business Performance
        • 4.8.4 Accord Pharmaceuticals Finasteride Business Development and Market Status
      • 4.9 Henan Topfond
        • 4.9.1 Henan Topfond Profiles
        • 4.9.2 Henan Topfond Product Information
        • 4.9.3 Henan Topfond Finasteride Business Performance
        • 4.9.4 Henan Topfond Finasteride Business Development and Market Status
      • 4.10 Zhejiang CONBA Pharmaceutical
        • 4.10.1 Zhejiang CONBA Pharmaceutical Profiles
        • 4.10.2 Zhejiang CONBA Pharmaceutical Product Information
        • 4.10.3 Zhejiang CONBA Pharmaceutical Finasteride Business Performance
        • 4.10.4 Zhejiang CONBA Pharmaceutical Finasteride Business Development and Market Status
      • 4.11 Shandong Renhetang Pharmaceutical
      • 4.12 Guangdong Eashu Pharmacetical

      5 Market Performance for Manufacturers

      • 5.1 Global Finasteride Capacity (K Units) and Market Share by Manufacturers 2013-2018
      • 5.2 Global Finasteride Sales (K Units) and Market Share by Manufacturers 2013-2018
      • 5.3 Global Finasteride Revenue (M USD) and Market Share by Manufacturers 2013-2018
      • 5.4 Global Finasteride Price (USD/Unit) of Manufacturers 2013-2018
      • 5.5 Global Finasteride Gross Margin of Manufacturers 2013-2018
      • 5.6 Market Concentration

      6 Regions Market Performance for Manufacturers

      • 6.1 China Market Performance for Manufacturers
        • 6.1.1 China Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.1.2 China Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.1.3 China Finasteride Price (USD/Unit) of Manufacturers 2013-2018
        • 6.1.4 China Finasteride Gross Margin of Manufacturers 2013-2018
        • 6.1.5 Market Concentration
      • 6.2 USA Market Performance for Manufacturers
        • 6.2.1 USA Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.2.2 USA Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.2.3 USA Finasteride Price (USD/Unit) of Manufacturers 2013-2018
        • 6.2.4 USA Finasteride Gross Margin of Manufacturers 2013-2018
        • 6.2.5 Market Concentration
      • 6.3 Europe Market Performance for Manufacturers
        • 6.3.1 Europe Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.3.2 Europe Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.3.3 Europe Finasteride Price (USD/Unit) of Manufacturers 2013-2018
        • 6.3.4 Europe Finasteride Gross Margin of Manufacturers 2013-2018
        • 6.3.5 Market Concentration
      • 6.4 Japan Market Performance for Manufacturers
        • 6.4.1 Japan Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.4.2 Japan Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.4.3 Japan Finasteride Price (USD/Unit) of Manufacturers 2013-2018
        • 6.4.4 Japan Finasteride Gross Margin of Manufacturers 2013-2018
        • 6.4.5 Market Concentration
      • 6.5 Korea Market Performance for Manufacturers
        • 6.5.1 Korea Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.5.2 Korea Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.5.3 Korea Finasteride Price (USD/Unit) of Manufacturers 2013-2018
        • 6.5.4 Korea Finasteride Gross Margin of Manufacturers 2013-2018
        • 6.5.5 Market Concentration
      • 6.6 India Market Performance for Manufacturers
        • 6.6.1 India Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.6.2 India Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.6.3 India Finasteride Price (USD/Unit) of Manufacturers 2013-2018
        • 6.6.4 India Finasteride Gross Margin of Manufacturers 2013-2018
        • 6.6.5 Market Concentration
      • 6.7 Southeast Asia Market Performance for Manufacturers
        • 6.7.1 Southeast Asia Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.7.2 Southeast Asia Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.7.3 Southeast Asia Finasteride Price (USD/Unit) of Manufacturers 2013-2018
        • 6.7.4 Southeast Asia Finasteride Gross Margin of Manufacturers 2013-2018
        • 6.7.5 Market Concentration
      • 6.8 South America Market Performance for Manufacturers
        • 6.8.1 South America Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.8.2 South America Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.8.3 South America Finasteride Price (USD/Unit) of Manufacturers 2013-2018
        • 6.8.4 South America Finasteride Gross Margin of Manufacturers 2013-2018
        • 6.8.5 Market Concentration

      7 Global Finasteride Market Performance (Sales Point)

      • 7.1 Global Finasteride Capacity (K Units) and Market Share by Regions 2013-2018
      • 7.2 Global Finasteride Sales (K Units) and Market Share by Regions 2013-2018
      • 7.3 Global Finasteride Revenue (M USD) and Market Share by Regions 2013-2018
      • 7.4 Global Finasteride Price (USD/Unit) by Regions 2013-2018
      • 7.5 Global Finasteride Gross Margin by Regions 2013-2018

      8 Development Trend for Regions (Sales Point)

      • 8.1 Global Finasteride Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.2 China Finasteride Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.3 USA Finasteride Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.4 Europe Finasteride Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.5 Japan Finasteride Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.6 Korea Finasteride Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.7 India Finasteride Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.8 Southeast Asia Finasteride Capacity and Growth, Sales Value and Growth Rate2013-2018
      • 8.9 Southeast Asia Finasteride Capacity and Growth, Sales Value and Growth Rate2013-2018

      9 Development Trend for Regions (Sales Point)

      • 9.1 Global Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.2 China Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.3 USA Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.4 Europe Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.5 Japan Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.6 Korea Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.7 India Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.8 Southeast Asia Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
      • 9.9 South America Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018

      10 Upstream Source, Technology and Cost

      • 10.1 Upstream Source
      • 10.2 Technology
      • 10.3 Cost

      11 Channel Analysis

      • 11.1 Market Channel
      • 11.2 Distributors

      12 Consumer Analysis

      • 12.1 Benign Prostatic Hyperplasia Industry
      • 12.2 Male Pattern Baldness Industry
      • 12.3 Other Industry

      13 Market Forecast 2019-2024

      • 13.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
        • 13.1.1 Global Finasteride Capacity (K Units) and Share by Regions 2019-2024
        • 13.1.2 Global Finasteride Capacity (K Units), Sales (K Units) and Growth Rate 2019-2024
        • 13.1.3 China Finasteride Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.4 USA Finasteride Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.5 Europe Finasteride Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.6 Japan Finasteride Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.7 Korea Finasteride Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.8 India Finasteride Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.9 Southeast Asia Finasteride Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.1.10 South America Finasteride Capacity (K Units), Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
        • 13.3.1 Overall Market Performance
        • 13.3.2 Type I Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 13.3.3 Type II Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.4 Sales by Application 2019-2024
        • 13.4.1 Overall Market Performance
        • 13.4.2 Benign Prostatic Hyperplasia Sales and and Growth Rate 2019-2024
        • 13.4.3 Male Pattern Baldness Sales and and Growth Rate 2019-2024
        • 13.4.4 Other Sales and and Growth Rate 2019-2024
      • 13.5 Price (USD/Unit) and Gross Profit
        • 13.5.1 Global Finasteride Price (USD/Unit) Trend 2019-2024
        • 13.5.2 Global Finasteride Gross Profit Trend 2019-2024

      14 Conclusion

      This report focuses on top manufacturers in global market, with Sales, price, revenue and market share for each manufacturer, covering
      Merck
      Actavis
      Sandoz
      Teva Pharmaceuticals
      Cipla
      RelonChem
      Dr. Reddy
      Accord Pharmaceuticals
      Henan Topfond
      Zhejiang CONBA Pharmaceutical
      Shandong Renhetang Pharmaceutical
      Guangdong Eashu Pharmacetical
      ...

      On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
      Type I
      Type II

      By Application, the market can be split into
      China
      USA
      Europe
      Japan
      Korea
      India
      Southeast Asia
      South America

      By Regions, this report covers (we can add the regions/countries as you want)

      If you have any special requirements, please let us know and we will offer you the report as you want.


      Summary:
      Get latest Market Research Reports on Finasteride. Industry analysis & Market Report on Finasteride is a syndicated market report, published as Global Finasteride Market Professional Survey Report 2018. It is complete Research Study and Industry Analysis of Finasteride market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,800.00
      $5,500.00
      2,019.14
      3,966.16
      2,339.71
      4,595.86
      302,974.00
      595,127.50
      204,498.00
      401,692.50
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report